Chison Medical Technologies Co Ltd
SSE:688358
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chison Medical Technologies Co Ltd
SSE:688358
|
CN |
|
Wuhan Jingce Electronic Group Co Ltd
SZSE:300567
|
CN |
|
R
|
Relais Group Oyj
OMXH:RELAIS
|
FI |
|
China Logistics Property Holdings Co Ltd
HKEX:1589
|
CN |
|
N
|
Northern Region Cement Company SJSC
SAU:3004
|
SA |
|
Galaxy Gaming Inc
OTC:GLXZ
|
US |
|
Natori Co Ltd
TSE:2922
|
JP |
|
Rezolute Inc
NASDAQ:RZLT
|
US |
|
A
|
Aerosun Corp
SSE:600501
|
CN |
|
Emami Ltd
NSE:EMAMILTD
|
IN |
|
M
|
Max Sight Group Holdings Ltd
HKEX:8483
|
HK |
|
Biocept Inc
OTC:BIOCQ
|
US |
|
Newcapec Electronics Co Ltd
SZSE:300248
|
CN |
|
S
|
Sanix Inc
TSE:4651
|
JP |
|
Z
|
Zhejiang He Chuan Technology Corp Ltd
SSE:688320
|
CN |
|
A
|
Anheuser-Busch Inbev SA
JSE:ANH
|
BE |
|
S
|
Sunedison Infrastructure Ltd
BSE:531260
|
IN |
|
Honkarakenne Oyj
LSE:0EPR
|
FI |
|
Adani Power Ltd
NSE:ADANIPOWER
|
IN |
|
C
|
Cyber Media India Ltd
NSE:CYBERMEDIA
|
IN |
|
A
|
American Express Co
XETRA:AEC1
|
US |
|
S E Corp
TSE:3423
|
JP |
|
M
|
Megawide Construction Corp
XPHS:MWIDE
|
PH |
|
A
|
Authum Investment & Infrastructure Ltd
BSE:539177
|
IN |
Income Statement
Earnings Waterfall
Chison Medical Technologies Co Ltd
Income Statement
Chison Medical Technologies Co Ltd
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
417
N/A
|
439
+5%
|
463
+5%
|
381
-18%
|
446
+17%
|
449
+1%
|
428
-5%
|
484
+13%
|
459
-5%
|
435
-5%
|
444
+2%
|
469
+5%
|
456
-3%
|
457
+0%
|
450
-2%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(188)
|
(193)
|
(198)
|
(159)
|
(180)
|
(183)
|
(179)
|
(205)
|
(194)
|
(185)
|
(192)
|
(197)
|
(190)
|
(189)
|
(185)
|
|
| Gross Profit |
229
N/A
|
246
+8%
|
265
+8%
|
222
-16%
|
265
+20%
|
266
+0%
|
249
-6%
|
279
+12%
|
265
-5%
|
250
-6%
|
252
+1%
|
272
+8%
|
266
-2%
|
268
+1%
|
265
-1%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(112)
|
(121)
|
(129)
|
(147)
|
(158)
|
(159)
|
(146)
|
(157)
|
(155)
|
(155)
|
(168)
|
(167)
|
(163)
|
(168)
|
(162)
|
|
| Selling, General & Administrative |
(78)
|
(83)
|
(84)
|
(82)
|
(90)
|
(94)
|
(90)
|
(90)
|
(91)
|
(89)
|
(94)
|
(94)
|
(94)
|
(93)
|
(93)
|
|
| Research & Development |
(76)
|
(80)
|
(84)
|
(72)
|
(79)
|
(77)
|
(75)
|
(71)
|
(77)
|
(78)
|
(80)
|
(74)
|
(77)
|
(78)
|
(74)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
43
|
42
|
40
|
16
|
11
|
12
|
18
|
15
|
13
|
12
|
6
|
12
|
9
|
4
|
5
|
|
| Operating Income |
117
N/A
|
126
+7%
|
136
+8%
|
75
-45%
|
107
+43%
|
106
-1%
|
103
-3%
|
122
+18%
|
110
-9%
|
95
-14%
|
84
-11%
|
105
+25%
|
103
-2%
|
100
-2%
|
103
+2%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
10
|
32
|
44
|
41
|
39
|
50
|
34
|
38
|
45
|
25
|
19
|
48
|
44
|
40
|
48
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(1)
|
0
|
(1)
|
(1)
|
3
|
0
|
6
|
6
|
5
|
6
|
5
|
5
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
|
| Pre-Tax Income |
127
N/A
|
157
+24%
|
180
+14%
|
115
-36%
|
146
+27%
|
156
+7%
|
136
-13%
|
162
+19%
|
155
-4%
|
125
-19%
|
109
-13%
|
157
+44%
|
152
-3%
|
144
-5%
|
154
+7%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
(12)
|
(16)
|
(20)
|
(9)
|
(12)
|
(13)
|
(14)
|
(16)
|
(15)
|
(9)
|
(6)
|
(16)
|
(15)
|
(16)
|
(18)
|
|
| Income from Continuing Operations |
115
|
141
|
160
|
106
|
134
|
142
|
122
|
146
|
140
|
116
|
103
|
141
|
137
|
129
|
136
|
|
| Net Income (Common) |
115
N/A
|
141
+23%
|
160
+14%
|
106
-34%
|
134
+26%
|
142
+6%
|
122
-14%
|
146
+20%
|
140
-5%
|
116
-17%
|
103
-11%
|
141
+36%
|
137
-3%
|
129
-6%
|
136
+6%
|
|
| EPS (Diluted) |
1.02
N/A
|
0.7
-31%
|
6.52
+831%
|
0.94
-86%
|
1.19
+27%
|
1.26
+6%
|
1.09
-13%
|
1.33
+22%
|
1.25
-6%
|
1.04
-17%
|
0.93
-11%
|
1.25
+34%
|
1.22
-2%
|
1.15
-6%
|
1.21
+5%
|
|